PATENT CLAIM ANALYSIS

Application Number: 15934246
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "414000"]

Abstract:
Uses of compound of Formula I: or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof are described. The compounds of Formula I are useful as IDO1 inhibitors. These are also useful for the treatment and/or prevention of cancer and endometriosis.

Claim (Index 7):
The method according to  claim 1 , wherein R 1  and R 2  each independently represent H or halo.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15331446', '14711911', '14215852', '11350335', '13761712']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816636562413813
- 35 USC 102 Novelty (BERT): 0.6184273279367608
- Combined Prediction Score: 0.7653400234109193
- Mean Citation Score: 415.51952200000005
- Max Citation Score: 548.4024
- Similarity Product: 506.56529764623633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test